Effects of Psilocin and Psilocybin on Human 5-HT<sub>4</sub> Serotonin and H<sub>2</sub> Histamine Receptors in Perfused Hearts of Transgenic Mice
<b>Background/Objectives</b>: Hallucinogenic substances such as psilocybin, psilocin, ergometrine, ergotamine, and lysergic acid diethylamide (LSD) have been demonstrated to enhance the force of contraction (FOC), in part due to the phosphorylation of phospholamban in human atrial prepar...
Saved in:
| Main Authors: | Pauline Braekow, Joachim Neumann, Uwe Kirchhefer, Ulrich Gergs |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/7/1009 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans
by: Nilubon Thaoboonruang, et al.
Published: (2025-04-01) -
Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models
by: Dotun Adeyinka, et al.
Published: (2025-08-01) -
Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity
by: Kinderlehrer DA
Published: (2025-01-01) -
LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain
by: J Van Der Walt, et al.
Published: (2023-11-01) -
Chemical Composition and Biological Activities of <i>Psilocybe</i> Mushrooms: Gaps and Perspectives
by: Mateus A. Luz, et al.
Published: (2025-07-01)